Monoclonal and Oligoclonal Anti-PF4 Antibodies Mediate VITT

Background: ChAdOx1 nCoV-19 (AstraZeneca) and Ad26.COV2.S (Janssen Johnson & Johnson) vaccines against COVID-19 have been associated with thrombotic thrombocytopenic reactions referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT) characterized by the presence of platelet-activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Bandana, Kanack, Adam, Bayas, Antonios, George, Gemlyn, Abou-Ismail, Mouhamed Yazan Abou, Kohlhagen, Mindy, Christ, Monika, Naumann, Markus, Moser, Karen A, Smock, Kristi J, Grazioli, Alison, Murray, David L, Padmanabhan, Anand
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology. Published by Elsevier Inc. 2021
Materias:
331.Thrombosis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701560/
http://dx.doi.org/10.1182/blood-2021-153307

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8701560/
http://dx.doi.org/10.1182/blood-2021-153307

Ejemplares similares